30-day FRN

jbell on DSKJLSW7X2PROD with NOTICES

5674

Federal Register / Vol. 85, No. 21 / Friday, January 31, 2020 / Notices

Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Pregnancy and Neonatology Study Section.
Date: February 27–28, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz Carlton Hotel, 1150 22nd Street
NW, Washington, DC 20037.
Contact Person: Andrew Maxwell Wolfe,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Dr., Room 6214,
Bethesda, MD 20892, 301.402.3019,
andrew.wolfe@nih.gov.
Name of Committee: Oncology 1-Basic
Translational Integrated Review Group;
Molecular Oncogenesis Study Section.
Date: February 27–28, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel, 1700 Tysons
Boulevard, McLean, VA 22102.
Contact Person: Nywana Sizemore, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6204,
MSC 7804, Bethesda, MD 20892, 301–435–
1718, sizemoren@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Acute Neural Injury and Epilepsy
Study Section.
Date: February 27–28, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW, Washington, DC 20037.
Contact Person: Paula Elyse Schauwecker,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201,
Bethesda, MD 20892, 301–760–8207,
schauweckerpe@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Vaccines Against
Microbial Diseases Study Section.
Date: February 27–28, 2020.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 West
Mission Bay Drive, San Diego, CA 92109.
Contact Person: Jian Wang, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218,
MSC 7812, Bethesda, MD 20892, (301) 435–
2778, wangjia@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Nuclear and
Cytoplasmic Structure/Function and
Dynamics Study Section.
Date: February 27–28, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Smith, Ph.D.,
Scientific Review Officer, Center for

VerDate Sep<11>2014

17:16 Jan 30, 2020

Jkt 250001

Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–3717, jessica.smith6@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 27, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01794 Filed 1–30–20; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Collection of Grant
and Contract Data That May Be of
Interest to Historically Black Colleges
and Universities (HBCUs) and Small
Businesses; (Office of the Director)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH),
Office of the Director, Office of
Acquisitions and Logistics Management
(OALM), Small Business Program Office
(SBPO), has submitted to the Office of
Management and Budget (OMB) a
request for review and approval of the
information collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Rachel Kenlaw,
Program Analyst, NIH, Office of the
Director, Office of Acquisitions and
Logistics Management, Small Business
Program Office, 6100 Executive Blvd.,
Suite 6E01G, Rockville, MD 20852, or
SUMMARY:

PO 00000

Frm 00064

Fmt 4703

Sfmt 4703

call non-toll-free number (301) 451–
6827 or Email your request, including
your address, to: Rachel.Kenlaw@
nih.gov.
This
proposed information collection was
previously published in the Federal
Register on October 30, 2019, page
23681 (84 FR 23681) and allowed 60
days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment.
The National Institutes of Health,
Office of the Director, Office of
Acquisitions and Logistics Management,
Small Business Program Office, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995 unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Collection of
grant and contract data that may be of
interest to Historically Black Colleges
and Universities (HBCUs) and small
businesses, 0925 NEW, exp., date XX/
XX/XXXX, Office of the Director, Office
of Acquisitions and Logistics
Management, Small Business Program
Office, National Institutes of Health.
Need and Use of Information
Collection: Presidential Executive Order
13779, The White House Initiative to
Promote Excellence and Innovation at
HBCUs mandates agencies to assist in
strengthening HBCU’s ability for
equitable participation in Federal
programs and explore new ways to
improve the relationship between the
Federal Government and HBCUs. This
initiative establishes how each agency
intends to increase the capacity of
HBCUs to compete effectively for
federal grants, contracts, and
cooperative agreements.
The Path to Excellence and
Innovation (PEI) is a comprehensive
program to increase the capacity of
HBCUs as they pursue funding
opportunities at the NIH. The PEI
provides a platform to increase
transparency between HBCUs and the
NIH by promoting outreach events and
training opportunities while providing
technical assistance. Through this
initiative the SBPO will assist HBCUs in
identifying NIH contracts, grants, and
other funding programs to increase their

SUPPLEMENTARY INFORMATION:

E:\FR\FM\31JAN1.SGM

31JAN1

5675

Federal Register / Vol. 85, No. 21 / Friday, January 31, 2020 / Notices
institutional biomedical research
capacity. Currently, there are six HBCU
participants and each selected a
minimum of one small business teaming

partner to pursue NIH funding
opportunities with.
OMB approval is requested for 3
years. There are no costs to respondents

other than their time. The total
estimated annualized burden hours are
43.

ESTIMATED ANNUALIZED BURDEN HOURS
Form name

HBCU Pre-Solicitation Portal
Contracts and Grants.

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total annual
burden hours

for

Private Sector ...................................

13

10

20/60

43

Total ...........................................

...........................................................

........................

130

........................

43

Dated: January 25, 2020.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2020–01863 Filed 1–30–20; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Human Genome Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

jbell on DSKJLSW7X2PROD with NOTICES

Number of
respondents

Type of respondents

Name of Committee: National Advisory
Council for Human Genome Research.
Date: February 10–11, 2020.
Closed: February 10, 2020, 8:00 a.m. to
10:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Suite
1100, 6700–B Rockledge Drive, Bethesda, MD
20892.

VerDate Sep<11>2014

17:16 Jan 30, 2020

Jkt 250001

Open: February 10, 2020, 10:00 a.m. to 4:00
p.m.
Agenda: Report from Institute Director and
Reports from Program Staff.
Place: National Institutes of Health, Suite
1100, 6700–B Rockledge Drive, Bethesda, MD
20817.
Closed: February 10, 2020, 4:00 p.m. to
Adjournment.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Suite
1100, 6700–B Rockledge Drive, Bethesda, MD
20817.
Closed: February 11, 2020, 8:00 a.m. to
Adjournment.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Suite
1100, 6700–B Rockledge Drive, Bethesda, MD
20817.
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852, (301) 402–0838,
pozzattr@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto off Campus Federal Facilities. Visitors
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: http://
www.genome.gov/council, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)

PO 00000

Frm 00065

Fmt 4703

Sfmt 4703

Dated: January 27, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01796 Filed 1–30–20; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Surgical Sciences, Biomedical Imaging, and
Bioengineering.
Date: February 26, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weihua Luo, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC, 7854 Bethesda, MD 20892, 301–435–
1170, luow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA 19–
021: Maximizing the Scientific Value of

E:\FR\FM\31JAN1.SGM

31JAN1